SEC Form 4 · accession 0001140361-16-050392
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph D Keegan
Director
Period of report
Feb 3, 2016
Accepted (ET)
Feb 5, 2016 · 1:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2016 | A | 127,696 | $0.47 | A | 127,696 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On February 3, 2016, Mr. Keegan was granted 127,696 restricted stock units which vest one-third over each of the next three years on the anniversary of the grant date.